Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: Unlike the all-out defense that Buxton normally puts on display, the Twins were more than willing to play it safe with this injury. Buxton was placed on the seven-day injured list for players with concussion-like symptoms, just as first baseman C.J. Cron and left fielder Eddie Rosario returned from their injuries. The Twins also designated right-handed reliever Mike Morin for release or assignment Tuesday before their series opener against the New York Mets. “We’re not going to mess around, really, in any way,” manager Rocco Baldelli said. “This is serious stuff. The health of Buck is obviously the most important thing. I think it’s something that is already resolving itself in some ways, but something where I think this is the right move.” Buxton was hurt Saturday during his head-first, diving catch of a sinking line drive during a critical win at main division competitor Cleveland, forcing him out of the game in the eighth inning. Buxton, who was sidelined for 13 games last month with a bruised right wrist, has had his promising career so far stunted by a variety of injuries, in part due to the speedster’s fearless style in the outfield and on the bases. Buxton was announced Tuesday as the team’s annual winner of the Major League Baseball Players Alumni Association’s Heart and Hustle Award. “He hit the ground pretty hard, and this isn’t any sort of light injury,” Baldelli said. “He didn’t graze anything. He made a great play and hit the ground, and he gives his body up for this team every single night that he takes the field.” The Twins, who took a six-game lead in the AL Central over the Indians into Tuesday night, have managed to maintain the highest-scoring offense in the majors despite putting 10 different position players on the injured list over various points of this season. Rosario was out for 13 games with a sprained left ankle. “It’s been a tough couple of weeks when it comes to injuries and things like that, but I’m back today and I know what Buxton is going through is nothing bad and he’ll be back soon as well,” said Rosario, who’s second on the team with 20 homers and still leads the Twins with 60 RBIs. Because of the All-Star break, Cron only missed five games with right thumb inflammation, a condition that has bothered him for most of the season. “I’m just going to try to tape it up, I guess. Try to pretend as if nothing’s wrong and try to just keep going,” Cron said. “That’s really all you can do.” Morin had a 3.18 ERA in 23 appearances after being invited to spring training on a minor league contract. His somewhat surprising removal from the roster could be the precursor to the addition of a reliever or two on the trade market over the next two weeks. “When you make decisions like this, you can look back on them, and you’re not really sure because things are not obvious sometimes, but unfortunately we landed on the thought of designating Mike,” Baldelli said. “I have no doubt he’s going to land on his feet.” ___ More AP baseball coverage: https://apnews.com/MLB and https://twitter.com/AP_Sports
[EX A]: As Cron, Rosario return, Twins put Buxton on concussion list.

[EX Q]: Irish-born William Campbell and Japan’s Satoshi Omura won half of the prize for discovering avermectin, a derivative of which has been used to treat hundreds of millions of people with river blindness and lymphatic filariasis, or elephantiasis. China’s Tu Youyou was awarded the other half of the prize for discovering artemisinin, a drug that has slashed malaria deaths and has become the mainstay of fighting the mosquito-borne disease. She is China’s first Nobel laureate in medicine. Some 3.4 billion people, most of them living in poor countries, are at risk of contracting the three parasitic diseases. “These two discoveries have provided humankind with powerful new means to combat these debilitating diseases that affect hundreds of millions of people annually,” the Nobel Assembly at Sweden’s Karolinska Institute said. “The consequences in terms of improved human health and reduced suffering are immeasurable.”  Today, the medicine ivermectin, a derivative of avermectin made by Merck & Co, is used worldwide to fight roundworm parasites, while artemisinin-based drugs from firms including Novartis and Sanofi are the main weapons against malaria. Omura and Campbell made their breakthrough in fighting parasitic worms, or helminths, after studying compounds from soil bacteria. That led to the discovery of avermectin, which was then further modified into ivermectin. The treatment is so successful that river blindness and lymphatic filariasis are now on the verge of being eradicated. Omura, 80, said the real credit for the achievement should go to the ingenuity of the Streptomyces bacteria, whose naturally occurring chemicals were so effective at killing off parasites. “I really wonder if I deserve this,” he said after learning he had won the prize. “I have done all my work depending on microbes and learning from them, so I think the microbes might almost deserve it more than I do.”  Omura is professor emeritus at Kitasato University in Japan, while Campbell is research fellow emeritus at Drew University in Madison, New Jersey. “This was the work of a team of researchers so it is by no means my work, it’s our work,” said Campbell, 85, who learned of his prize in a pre-dawn phone call from Reuters that woke him at his home in North Andover, Massachusetts. “In the first decade, there were 70 authors that I co-authored papers with. That gives you some idea of the number of people involved,” he said. Tu, meanwhile, turned to a traditional Chinese herbal medicine in her hunt for a better malaria treatment, following the declining success of the older drugs chloroquine and quinine. She found that an extract from the plant Artemisia annua was sometimes effective but the results were inconsistent, so she went back to ancient literature, including a recipe from AD 350, in the search for clues. This eventually led to the isolation of artemisinin, a new class of anti-malaria drug, which was available in China before it reached the West. Tu, 84, has worked at the China Academy of Traditional Chinese Medicine since 1965. World Health Organization spokesman Gregory Hartl said the award of a Nobel prize for the discovery was a great tribute to the contribution of Chinese science in fighting malaria. “We now have drugs that kill these parasites very early in their life-cycle,” said Juleen Zierath, chair of the Nobel Committee. “They not only kill these parasites but they stop these infections from spreading.”     Death rates from malaria have plunged 60 percent in the past 15 years, although the disease still kills around half a million people a year, the vast majority of them babies and young children in the poorest parts of Africa. The 8 million Swedish crowns ($960,000) medicine prize is the first of the Nobel prizes awarded each year. Prizes for achievements in science, literature and peace were first awarded in 1901 in accordance with the will of dynamite inventor and businessman Alfred Nobel. Last year, the medicine prize went to three scientists who discovered the brain’s inner navigation system.
[EX A]: Beating parasites wins three scientists Nobel prize for medicine.

[EX Q]: Frates is fighting back from a summer health scare that landed him in the hospital while still trying to be a public face of amyotrophic lateral sclerosis, or ALS, a degenerative disease that destroys nerve cells, impairs physical functions and so far has no cure. The former Boston College baseball star, who can no longer speak or move, spent most of July in the hospital battling pneumonia and other infections. In July, a tweet erroneously reporting his demise led to worldwide headlines. Frates wryly countered by posting a short video of himself lying in a hospital bed with Pearl Jam’s “Alive” playing in the background. Using a computer system that lets him type out words through eye movements, Frates has been tweeting about his progress to his nearly 30,000 followers, along with regular musings about his family and friends, living with ALS and Boston sports. “lots of down days as you can imagine with als, sometimes you don’t feel human,” he tweeted Sept. 23. “Today I am definitely feeling sorry for myself, sukxx. but I will bounce back. Eff! you als.. Friggin a hole! !” In the weeks since his July health scare, the 32-year-old has re-emerged to accept honors and accolades across his home state of Massachusetts. Last month, he joined Boston Mayor Marty Walsh, Red Sox officials and the Boston College baseball team on the steps of City Hall to declare Sept. 5 “Pete Frates Day” in Boston. And former Red Sox slugger David Ortiz and other Boston sports legends feted Frates at Fenway Park to mark the release of a new book on his life, “The Ice Bucket Challenge: Pete Frates and the Fight Against ALS.” Half the proceeds benefit Frates and his family. Frates’ wife, Julie, said it’s been a difficult and busy few months, but she couldn’t persuade her husband to slow things down even if she wanted to. “He’s the one pushing to be out there,” she said. “We take all the lead from him.” The ice bucket challenge had been around for almost a year to benefit various causes. But Frates is credited with helping focus it on ALS specifically and taking it global using his wide network of supporters as an established ALS advocate. The challenge raised roughly $220 million in 2014, of which $115 million went to the ALS Association. A sequel campaign the next summer raised just over $1 million, according to the association. The ALS Association says it has committed more than $89 million of the 2014 windfall to research. “New, exciting research is just starting to pan out, and that’s drawing new talent to ALS research, and a lot of companies are now interested in ALS,” said Dr. Nazem Atassi, a Massachusetts General Hospital neurologist whose ALS research benefited from ice bucket challenge money. “It’s the perfect environment for drug discovery.” Among the most promising developments to come out of research funded by the challenge has been the identification of at least four genes that contribute to the disease, a critical step toward developing new treatments, said Kevin Eggan, a professor at Harvard University who specializes in ALS. Another development that gives the Frates family hope is Radicava, a drug approved in May by the U.S. Food and Drug Administration following testimony from the Frates and other advocates. It’s the first new treatment approved specifically for ALS in 22 years. Frates’ mother, Nancy, said they’re applying to get her son on the drug, even though it’s not clear how it might help, given his advanced condition. The medication, which was developed in Japan without funding from the ice bucket challenge, has been shown to slow the disease in recently diagnosed patients. “You just want it to stop,” Nancy said. “You want someone to say this disease is not tearing through your loved one’s body anymore.” ALS is still finding new ways to attack Frates, said his father, John, a city councilor in Beverly who quit his financial services job to help care for his son after he was diagnosed in 2012. Frates’ bladder stopped working last year, requiring his urine now to be drained with a catheter every three hours, John Frates said. “It’s amazing he’s tolerating all of it. It just shows the courage, will and determination he has to be with us,” Frates’ father said. “He’s as incapacitated as a human being can be. That’s his quality of life.” ___ Follow Philip Marcelo at twitter.com/philmarcelo. His work can be found at https://www.apnews.com/search/philip%20marcelo
[EX A]:
ALS patient behind ice bucket challenge: I will bounce back.